Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (24) Chen, Wei Prof. Dr. (2) Daniel, Peter Prof. Dr. (1) Escobar Fernandez, Helena Dr. (1) Fröhlich, Janine (1) Hübner, Norbert Prof. Dr. (2) Ivics, Zoltan Dr. (30) Izsvak, Zsuzsanna Dr. (34) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (2) Marg, Andreas Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Prigione, Alessandro Prof. Dr. (1) Saar, Kathrin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Singh, Manvendra Dr. (3) Spuler, Simone Prof. (1) Uckert, Wolfgang Prof. Dr. (10) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (3) (-) Leisegang, Matthias Prof. Dr. rer. nat. (4) Bioinformatik der Genregulation (1) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genom-Editierung & Krankheitsmodelle (4) Genomdiversifikation & Integrität (1) Genomics (2) Immunregulation und Krebs (7) Kardiale MRT (2) Magnetic Resonance (7) Mathematische Modellierung zellulärer Prozesse (1) (-) Mobile DNA (1) (-) Molekulare Immunologie und Gentherapie (8) Protein Production and Characterization (1) Proteom Dynamik (3) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Proteomics and Metabolomics (1) RNA Biologie und Posttranscriptionale Regulation (4) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (4) Zelluläre Neurowissenschaften (2) 2006 (1) (-) 2007 (1) (-) 2008 (1) (-) 2010 (1) 2011 (1) 2013 (3) (-) 2015 (2) (-) 2016 (4) 2017 (2) 2018 (3) 2020 (2) 2022 (2) 9 Ergebnisse: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Mobile DNAMolekulare Immunologie und Gentherapie 20072008201020152016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau